Marcy l'Etoile, France - April 21, 2010. Sales up 6.4% at constant exchange rates and scope of consolidation.
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2010.
Net sales for the first quarter amounted to €307 million, up 6.4% at constant exchange rates and scope of consolidation (on a like-for-like basis) versus the first quarter of 2009.
Download
- Filename
- pr_biomerieux_q1_sales_2010_en1.pdf
- Size
- 115 KB
- Format
- application/pdf